U.S. Advisory Panel: HPV Test Should Be Given Together with Pap Smear to Detect Cervical Cancer

March 22, 2012 - PRLog -- The Center for the Biology of Chronic Disease (CBCD) has recently learned that a U.S. advisory panel said “Women older than 30 should be screened for human papillomavirus every five years with a Pap test to detect cervical cancer though the results may lead to “significant” harm.” The CBCD is in agreement with the U.S. advisory panel.

An editorial associated with the guidelines, published yesterday in the Annals of Internal Medicine said “False positive test results can lead to over diagnosis, misdiagnosis and the potential for unnecessary diagnostic testing, procedures, treatments and their inherent risks.”

What does that mean? Debbie Saslow, director of breast and gynecologic cancer for the American Cancer Society explains, “Pap tests have been done yearly in the past, but we now know that annual screening is not needed and in fact can lead to harm from treatment of cell changes that would never go on to cause cancer.”

The CBCD believes this is highly significant. Notice the sentence, “annual screening is not needed and in fact can lead to harm from treatment of cell changes that would never go on to cause cancer.”

Thus, it can be seen that abnormal cervical cells do not always go on to become cancer. In fact, in 90% of the cases, the body fixes itself without any sort of medical intervention of any kind. Thus, the scare tactics used by some to manipulate parents into vaccinating their children (both boys and girls) with the HPV vaccines are, largely, baseless.

While Gardasil is supposed to protect against HPV types 6, 11, 16, and 18, there are 150 other types of HPV. At least 15 of these can cause cancer. Gardasil provides no protection against these other strains. [1]

Moreover, the end point of all the efficacy studies for Gardasil was not, in fact, prevention of cancer. Researchers could not actually evaluate the development of cervical cancer following vaccination because this normally takes 20 to 40 years and their studies stopped after just five. Merck’s scientists decided that the presence of abnormal cervical cells was a legitimate “surrogate end point,” or substitute for cancer. They used this hypothesis even though the fact of the matter is that there is no evidence that the cervical lesions they chose as their end point would eventually lead to cancer. [2]

There also happen to be HPV DNA fragments in the Gardasil vaccine.

While the FDA says on their website, “The presence of DNA fragments is expected in Gardasil and not evidence of contamination.” and “Gardasil does contain recombinant HPV L1-specific DNA fragments, but these are not contaminants. DNA encoding the HPV L1 gene is used in the vaccine manufacturing process to produce the virus-like particles that make up the vaccine. The presence of these DNA fragments is expected, is not a risk to vaccine recipients, and is not a safety factor.” [3]

Like the Romans, the CBCD believes knowledge is power. The issue is not one of contamination, but rather the fact that the inclusion of DNA fragments is simply a by-product of the vaccine manufacturing process.

No known process can completely remove DNA from the vaccine.

While the FDA says there is no risk and that the vaccine remains safe, the CBCD disputes this assertion. The CBCD is encouraging biologists, virologists, geneticists and scientists to obtain a copy of “Microcompetition with Foreign DNA and the Origin of Chronic Disease.” Dr. Hanan Polansky wrote this book.

The book discusses a discovery that identifies the origin of many chronic diseases, such as HPV caused cancers, Multiple Sclerosis, hepatitis, atherosclerosis, stroke, cancer, obesity, diabetes, lupus, thyroiditis, osteoarthritis, rheumatoid arthritis, and alopecia.

The book is available as a free download from the CBCD website. (http://www.cbcd.net )

“I found that the theory is groundbreaking and will likely open doors to many exciting research areas and treatment options … biology and medicine lag behind and remain experimental disciplines, which are heavy on experimental data but thin on applicable theories that could guide future directions. In this sense, Dr. Polansky’s book is nothing short of revolutionary.” – Liqun Zhang, PhD – Research Associate, Cystic Fibrosis/Pulmonary Research and Treatment Center, University of North Carolina at Chapel Hill

The CBCD endorses Dr. Polansky’s discovery and invites both the media as well as scholars to contact us for dialogue regarding the theory.

For more information on the Center for the Biology of Chronic Disease, or to schedule an interview with Dr. Polansky on the subject of Microcompetition with Foreign DNA, please visit http://www.cbcd.net or call 585-250-9999.

References:

[1] Human Papillomaviruses and Cancer, National Cancer Institute, September 7, 2011, http://www.cancer.gov/cancertopics/factsheet/Risk/HPV/print

Haug CJ, Human Papillomavirus Vaccination – Reasons for Caution, New England Journal of Medicine, August 21, 2008, 359; 861-862.

[2] Rothman SM and Rothman DJ, Marketing HPV Vaccine: Implications for Adolescent Health and Medical Professionalism, JAMA 2009, 302(7); 781-786.

[3]http://www.fda.gov/BiologicsBloodVaccines/Vaccines/Approv...

# # #

The Center for the Biology of Chronic Disease (CBCD, http://www.cbcd.net) is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments for these diseases.

The CBCD published the “Purple” book entitled “Microcompetition with Foreign DNA and the Origin of Chronic Disease” written by Dr. Hanan Polansky. The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between the DNA of latent (chronic) viruses and the onset of chronic diseases. Dr. Polansky’s book is available as a free download from the CBCD website.

We invite biologists, virologists, and scientists everywhere to download Dr. Polansky’s book here: http://cbcd.net/.